PeakData raises 12 million Swiss francs

The Zug-based firm PeakData has closed a Series A financing round in which it raised the equivalent of 12 million Swiss francs. The round was led by Albion VC from London, although Octopus Ventures, also based in London, and the Berlin-based Heal Capital were involved in the process as well. These firms have opted to invest in the Human Resources platform from PeakData, which identifies the best-suited Healthcare Professional (HCP) for pharmaceutical firms in each individual case on the basis of Artificial Intelligence (AI). The company’s aim is to ensure that patients benefit from innovative new medicines much more quickly, further details of which can be found in a press release.

With PeakData, pharmaceutical companies can “for the first time uncover the whole HCP universe for any given therapeutic area to focus resources only on those HCPs that matter most”. The platform allows users to react quickly to market changes and come across emerging experts who “may previously not have been on their radar”.

PeakData was launched in 2018. According to information from the company itself, it recorded sixfold growth in 2021 by increasing the number of employees from 12 to 70. Its platform is now being used by more than half of all major European pharmaceutical firms. Over the next five years, the aim is for “the vast majority of pharmaceutical companies around the globe and in as many drug markets as possible” to use the platform.